Search - tctmd.com

Displaying 261 - 280 of 319

Sort: Relevancy | Date

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

Registry Suggests Link Between PCI Access Route, Kidney Damage

Caitlin E. Cox

March 05, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Presenter: Philip Green

October 31, 2013

News Industry News

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

October 31, 2013

Presentation TCT 2013

The Role of Gait Speed as a Measure of Frailty in the Evaluation of Elderly Patients With Severe Aortic Stenosis for Treatment

Presenter: Elizabeth M. Holper

October 29, 2013

Presentation TCT 2013

What is Frailty and Why is it So Important?

Presenter: Philip Green

October 27, 2013

Presentation TCT 2013

Insights on Frailty from the U.S. CoreValve Extreme Risk Registry

Presenter: Jeffrey Popma

October 27, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Meta-analysis Finds Greater Patency, Complications with Aortoiliac Surgery vs. Stenting

Yael L. Maxwell

August 13, 2013

Presentation TVT 2013

We can do it, but should we do it? Quantifying Frailty and Futility

Presenter: Karen Holst Lisby

June 14, 2013

News Industry News

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

June 14, 2013

Presentation TVT 2013

Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights

Presenter: Philip Green

June 12, 2013

Presentation TVT 2013

Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools

Presenter: Philip Green

June 12, 2013

Presentation TVT 2013

Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial

Presenter: Jeffrey Popma

June 12, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

Advertisement

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Registry Suggests Link Between PCI Access Route, Kidney Damage

Medtronic CoreValve® System Obtains Early FDA Approval

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

The Role of Gait Speed as a Measure of Frailty in the Evaluation of Elderly Patients With Severe Aortic Stenosis for Treatment

What is Frailty and Why is it So Important?

Insights on Frailty from the U.S. CoreValve Extreme Risk Registry

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Meta-analysis Finds Greater Patency, Complications with Aortoiliac Surgery vs. Stenting

We can do it, but should we do it? Quantifying Frailty and Futility

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights

Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools

Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial

Tumor Marker Predicts TAVR Outcomes

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content